Rocakinogene sifuplasmid Uses, Dosage, Side Effects and more
Rocakinogene sifuplasmid is under investigation in clinical trial NCT03491683 (INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-diagnosed Glioblastoma (GBM)).
| Attribute | Details |
|---|---|
| Trade Name | Rocakinogene sifuplasmid |
| Generic | Rocakinogene sifuplasmid |
| Rocakinogene sifuplasmid Other Names | Rocakinogene sifuplasmid |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
